Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Return on Equity (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Return on Equity readings, the most recent being 0.38% for Q1 2026.

  • On a quarterly basis, Return on Equity rose 12.0% to 0.38% in Q1 2026 year-over-year; TTM through Feb 2026 was 0.38%, a 12.0% increase, with the full-year FY2025 number at 0.5%, down 10.0% from a year prior.
  • Return on Equity reached 0.38% in Q1 2026 per CBIH's latest filing, down from 0.45% in the prior quarter.
  • The five-year high for Return on Equity was 1.53% in Q3 2023, with the low at 0.26% in Q1 2025.
  • A 4-year average of 0.6% and a median of 0.45% in 2024 define the central range for Return on Equity.
  • Year-over-year, Return on Equity crashed -117bps in 2024 and then increased 12bps in 2025.
  • Year by year, Return on Equity stood at 1.12% in 2023, then crashed by -71bps to 0.33% in 2024, then surged by 36bps to 0.45% in 2025, then dropped by -15bps to 0.38% in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Return on Equity are 0.38% (Q1 2026), 0.45% (Q4 2025), and 0.46% (Q3 2025).